Waiting lists for attention deficit hyperactivity disorder and autism assessments across NHS England have reached crisis point, with some regions now imposing minimum two-year delays for initial evaluations. The bottleneck reflects a health service struggling to manage a dramatic shift in clinical understanding and public awareness of these conditions, leaving nearly 1 million people awaiting ADHD assessment and approximately 295,000 waiting for autism diagnosis.
The scale of the challenge has become apparent through formal NHS commissioning guidance. NHS England's 2026/27 payment guidance sets indicative prices of £850 for adult face-to-face ADHD assessments and £1,150 for adult autism assessments, yet capacity remains insufficient to meet demand. In the North East and North Cumbria region, providers are working to an approximately 78-week minimum waiting time for initial assessment in 2026/27, with recently referred patients unlikely to be seen during the current financial year.
The average wait for ADHD assessment now exceeds one year at 64 weeks. These delays create serious consequences beyond medical care alone: families face postponed access to specialist support in schools, delayed eligibility for disability benefits, and extended periods without formal recognition of their needs. The assessment process has become the critical gateway through which individuals obtain access to support, adjustments and formal recognition across multiple public systems.
How did referral numbers rise so dramatically?
Formal diagnosis of both conditions has accelerated sharply since 2020. Between 2020 and 2022, annual incidence of autism diagnosis in three- to 25-year-old males rose from 185 to 580 per 100,000, while in females the rate climbed from 45 to 320 per 100,000. This sixfold increase in female diagnoses reflects improved clinical understanding and greater recognition of unmet needs in groups historically under-identified by services.
A government-commissioned independent review into these trends, launched on 4 December 2025 and due to inform the 10 Year Health Plan, examined the drivers of this surge. The review found that improved clinical understanding and recognition of previously unmet needs, particularly in girls and young women, account for part of the increase. Institutional demand also plays a role: schools and the benefit system both require formal diagnosis as a practical mechanism for accessing support and adjustments.
The broader context includes multiple reinforcing factors: the psychological impact of the pandemic, economic insecurity, greater public awareness of ADHD and autism, and a significant decline in stigma surrounding these diagnoses. Referral thresholds have lowered as clinicians recognise conditions in populations previously missed by services.
Is the rise a sign of genuine unmet need or overdiagnosis?
The independent review's findings, published earlier this year, rejected a simple either-or framing.
Unmet needs, misdiagnosis and concerns about over-medicalisation can coexist in the same system,the review stated, acknowledging that both genuine underdiagnosis and concerns about diagnostic inflation exist within the same NHS structures.
What was not disputed was that more people, especially younger people, are experiencing distress and seeking help as a result. The review concluded that some groups historically under-identified are now entering services in greater numbers, representing a correction of previous diagnostic gaps rather than pure expansion of the diagnostic category.
However, the culture war surrounding these diagnoses has intensified. Some commentators dismiss rising diagnosis rates as the product of faddish overdiagnosis, while others view them as belated recognition of genuine conditions with real-life challenges. Professor Peter Fonagy, who led the independent review, publicly rejected the "snowflake generation" framing in interviews on 21 September 2026, stating that rising distress among young people is real. The review's evidence supports his position: rising distress and help-seeking behaviour are documented across multiple health and education settings.
What are the knock-on effects of assessment delays?
The bottleneck in diagnostic services creates cascading problems throughout the health and social care system. Delays in assessment mean delays in access to medical treatment, specialist support in educational settings, and eligibility determination for disability benefits. For families and individuals, the wait becomes a period of continued uncertainty and unmet need.
The broader mental health system is also under strain. Emergency department visits by children in mental health crisis surged 36% between 2019 and 2025, with over 6,200 young people waiting more than 12 hours in unsuitable emergency settings. Medical leaders have warned that A&Es are not appropriate environments for vulnerable children and called for urgent investment in crisis services.
NHS leaders have also raised alarm about cost control and service quality. NHS leaders warn that autism and ADHD care risks descending into chaos as costs spiral out of control and unregulated private providers proliferate, with pricing varying tenfold for identical services across regions.
Are private providers offering an alternative?
Under the NHS "right to choose" scheme, patients in England can request GP referral to certain private providers funded by the NHS rather than waiting for local services. However, this route has created new concerns. Some psychiatrists report that more people are seeking ADHD diagnoses without pursuing treatment, pointing to poor-quality private assessments and questioning whether ADHD is being treated as an identity rather than a medical condition.
Some integrated care boards have reduced activity levels for 2026/27, meaning waiting times may extend beyond March 2027. Psychiatry UK lists Cheshire and Merseyside autism waits at 78+ weeks, illustrating how the crisis extends across multiple regions and service models.
What happens next?
The independent review's final report was expected to be published imminently as of mid-September 2026, with its findings set to inform the government's 10 Year Health Plan commitment to tackle the mental health crisis in adults and children. The review's task now moves beyond documenting the problem to recommending practical solutions for expanding NHS capacity and improving diagnostic pathways.
The 2026/27 minimum waiting time frameworks currently in place across NHS regions run until 31 March 2027, after which the system's ability to manage demand remains uncertain without significant additional investment and workforce expansion.
Key Facts
- Nearly 1 million people in England await ADHD assessment, with average waits exceeding 64 weeks; approximately 295,000 await autism diagnosis
- Autism diagnosis rates in three- to 25-year-old females rose sixfold between 2020 and 2022, from 45 to 320 per 100,000
- Some NHS regions have imposed 78-week minimum waiting times for initial assessment in 2026/27, with recently referred patients unlikely to be seen before March 2027
- Assessment delays prevent access not only to medical treatment but to specialist school support and disability benefits eligibility
- The independent review found that unmet needs, misdiagnosis and concerns about over-medicalisation coexist within the same system
